INTRODUCTION
Allergy to aeroallergens is one of the determining factors for the occurrence of asthma. [1] [2] [3] [4] In most parts of the world, mites are the commonest source of perennial respiratory allergies. [4] [5] [6] Of the many species of mites known to date, only a few are responsible for respiratory allergies. These include for dust mites the following: Dermatophagoides
pteronyssimus (DP), Dermatophagoides farinae (DF) et Euroglyphus maynei and for storage mites: Blomia tropicalis (BT), Lepidoglyphus destructor, Glycyphagus domesticus,
Tyrophagus putrescenciae, Acarus siro. [5, 7, 8] The prevalence of sensitisation to different species of mites varies across regions in the world, mostly influenced by differences in climatic and environmental conditions. [9] [10] [11] [12] Allergenic sensitisation and particularly sensitisation to mites has been less investigated in patients with respiratory atopy in sub-Saharan Africa, causing the management of these patients to be less than optimal in this part of the world. The aims of the current study was to determine the prevalence of sensitisation to mites and the distribution of such sensitisation across the three commonest mites (DP, DF, BT) among adolescents and adults with asthma in Yaounde, Cameroon; and additionally, to investigate the determinants of sensitisation to mites in these patients.
MATERIALS AND METHODS

Study setting and participants
The study was conducted in the outpatient department of the pneumology service of the Yaounde Jamot Hospital (YJH) and the CEDIMER private centre. YJH is a public hospital and the referral centre for chest diseases for the capital city of Cameroon (Yaounde) and surrounding areas. CEDIMER is a private medical practice which offers ambulatory care to patients in Yaounde. The study was approved by the ethics committee of the two participating health facilities.
Methods
This was a cross-sectional study involving all consenting adolescents (age >10 years) and adults Cameroonians followed for asthma from January 2012 through June 2013 (18 months).
Diagnosis of asthma was confirmed by a specialist physician, and was based on the criteria of the Global Initiative for Asthma (GINA). [13] Demographic and clinical data were collected including: age, sex, ethnic group, known duration of asthma, family history of asthma, other existing allergic conditions (rhinitis, conjunctivitis, and atopic dermatitis) and smoking. obstruction, sneezing and itching. Persisting rhinitis was retained for a patient who reported symptoms for at least four days per week and during four weeks or more; otherwise rhinitis was considered as intermittent. [14] Diagnosis of atopic dermatitis was based on the criteria of the United Kingdom Working Party. [15] The control of asthma was assessed with the use of the Asthma Control Questionnaire (ACQ). [16, 17] Asthma was considered to have been insufficiently controlled in the week preceding the inclusion, in the presence of an ACQ score of one or greater. [16, 17] The baseline forced expiratory volume in the first second (FEV1) was recorded for all patients in the absence of any exacerbation. Predicted FEV1 was based on the 2012 equations of the Global Lung Initiative for Blacks subjects. [18] Prick-test and standardised allergenic extracts of Stallergenes Laboratories (Anthony, France)
were used for skin tests.
The following perennial aeroallergens were tested: mites (Dermatophagoïdes pteronyssinus, Dermatophagoïdes farinae and Blomia tropicalis), moist (Alternaria alternata), Blattella germanica, cat dander and dog dander. Dilution solution of the allergenic extracts and histamine were used respectively as negative and positive controls.
A prick test was considered positive if the diameter of the papula was greater than 3 mm, relative to the diameter of the negative control; or 50% that of the positive control. Patients for whom skin allergologic tests were not performed were excluded from the study. Logistic regressions models were employed to investigate the determinants of sensitisation to mites. A p-value <0.05 was used to characterise statistically significant results.
Statistical methods
Data
RESULTS
General characteristics of the study population
Of the 209 asthmatic adolescent and adults received in consultations during the inclusion period, eight (3.8%) did not receive the skin allergologic tests and were excluded. Clinical and demographic characteristics for the 201 patients in the final analytic sample are summarised in 
Prevalence of the sensitisation to mites
The prevalence of the sensitisation to the three mites tested in the current study was 67.2%
(135/201), with a 95% confidence interval of 60.7-73.7%. The prevalence of the sensitisation to each of the species was 53.2% for DP, 49.8% for DF and 47.8% for BT. The distribution of the sensitisation of our participants to different species of mite is presented in Table 2 . Thirtyseven (27.4%) patients had an isolated sensitisation to one of the three species of mites and mono-sensitisation to mites (i.e. absence of sensitisation to other perennial aeroallergens) was present in 70 (51.9%) patients. Isolated sensitisation to BT was the most frequent and was found in 15 (11.1%) patients. The most common sensitisation to two species of mites was the co-sensitisation to DP and DF, which was found in 17 (12.6%) patients. Seventy (51.9%) patients had a sensitisation to the three species of mites tested.
Determinants of the sensitisation to mites
The prevalence of the sensitisation to mites was similar between women and men (63.6% vs.
73.9%, p=0.157) and the median age was similar between sensitised patients and non- Mites are minuscule cosmopolite arthropods which leave and prosper in humid zones (optimal humidity of 60-80%) and at an optimal temperature of 20 to 30 o C. [5, 8] Of the hundreds of species of mites identified so far, a few are responsible for over 90% of allergenic sensitisation. [5] In most parts of the world, DP and DF account for over 70-80% of sensitisations due to mites. [7] However, during the last decade, sensitisation to BT has been increasingly reported in inter-tropical and temperate zones. [10, 19] The prevalence of the sensitisation to mites to difference species of mites among atopic patients varies substantially across regions around the world. For instance, the prevalence of sensitisation to mites in patients with asthma varies between 31% and 88% in Europe, [9] between 39% and 56% in America, [9, 10] and between 53 to 88% in Asia and Oceania. [9, 11, 12] The prevalence in our study was 67.2%, with a sensitisation to each of the three species (DP, DF and BT) found in about half of our patients. Inclusion of these three mites in the pool of allergologic test appears to be primordial in this setting, considering the fact that more than a third of the patients had an isolated sensitisation to one of the three mites. This could possibly reflect a cross-sensitisation due to shared allergens across species, or a true multiple sensitisation to major allergens of these mites. [7] While about half of our patients with asthma had rhinitis, the proportion was much higher among patients sensitised to mites, and regardless of the clinical form of rhinitis. This suggests that respiratory allergy to mites affects the entire respiratory tract including both the upper and the lower respiratory airways. We did not find other significant differences in the clinical characteristics between patients who were sensitised to mites and those who were not.
For instance, sensitisation to mites was not associated with age at the clinical onset of asthma, sex, family history of asthma, ethnicity or alteration of lung functions. Therefore, unlike the presence of rhinitis, other clinical variables may not be useful for the screening of patients for allergy to mites.
In our sample, sensitisation to mites was independently associated with sensitisation to
Alternaria and sensitisation to Blattella germanica. Indeed, a third and patients sensitised to mites were also sensitised to Blattella germanica. These associations at least in part could be explained by the cross reactivity between mites and cockroaches via tropomyosin, but could also reflect multiple sensitisation. [20] [21] [22] The association between sensitisation to mites and sensitisation to Alternaria likely reflects a multiple sensitisation, considering the phylogenic distance between the two species. Not so much has been reported on this association which deserved further investigation and confirmation in other setting in tropical Africa. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60   F  o  r  p  e  e  r  r  e  v  i  e  w  o  n  l  y   8 This study has some limitations including the reliance on skin tests alone to diagnose sensitisation and enrolment of patients from only two health facilities in the city of Yaounde.
Indeed, measurements of specific immunoglobulin E could reveal more sensitisations, in particular in patients with hyporeactivity to skin tests. The two recruitment health facilities for this study are referral centres for chest diseases in Yaounde. It is therefore possible that patients recruited from these facilities are representative of the population of patients with asthma seen across all health facilities in the city.
In conclusion, sensitisation to mites is frequent among patients with asthma in Yaounde,
where it is frequently associated with a sensitisation to Alternaria and/or sensitisation to Blattella germanica. The presence of rhinitis in patients with asthma is suggestive of a sensitisation to mites. Systematically investigating patients with asthma for an allergy to mites as well as the determinants of such an allergy will help optimising the care of patients with asthma in this setting through a combination an aetiological treatment for the allergy with a symptomatic treatment for asthma, in order to modify the natural history of the disease.
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ABSTRACT
Objectives: Sensitisation of asthmatic patients to mites in sub-Saharan Africa has been less described. The aim of this study was to assess the prevalence and determinants of sensitisation to mites in asthmatic adolescents and adults in Yaounde, Cameroon.
Design: This was cross-sectional study. Logistic regressions models were employed to investigate the determinants of sensitisation to mites.
Setting: This study was carried out at the Jamot Hospital and CEDIMER private centre, in
Yaounde, capital city of Cameroon.
Participants: All asthmatic patients received in consultations from January 2012 to June 2013 and in whom prick-skin tests for perennial aeroallergens were performed, were included. 
ARTICLE SUMMARY Article focus
• To investigate current prevalence and determinants of sensitisation to mites in patients with asthma in a sub-Saharan Africa country.
Key messages
• Two out of three asthmatic patients in Yaounde have a sensitisation to mites;
• Intermittent and persistent rhinitis are more frequent in patients sensitised to mites;
• Sensitisation to Alternaria and to Blattella germanica are the main predictors of sensitisation to mites.
Strengths and limitations
• This was a first study exploring sensitization to mites in Cameroon.
• This study uses robust methods to assess determinants of sensitisation in asthma patients.
• The study was conducted only in two centres [5, 7, 8] The prevalence of sensitisation to different species of mites varies across regions in the world, mostly influenced by differences in climatic and environmental conditions.[9-12] Allergenic sensitisation and particularly sensitisation to mites has been less investigated in patients with respiratory atopy in sub-Saharan Africa, causing the management of these patients to be less than optimal in this part of the world. The aims of the current study was to determine the prevalence of sensitisation to mites and the distribution of such sensitisation across the three commonest mites (DP, DF, BT) among adolescents and adults with asthma in Yaounde, Cameroon; and additionally, to investigate the determinants of sensitisation to mites in these patients.
MATERIALS AND METHODS
Study setting and participants
Methods
Diagnosis of asthma was confirmed by a specialist physician, and was based on the criteria of the Global Initiative for Asthma (GINA). [13] Demographic and clinical data were collected including: age, sex, ethnic group, known duration of asthma, family history of asthma, other existing allergic conditions (rhinitis, conjunctivitis, and atopic dermatitis) and smoking. the allergenic extracts and histamine were used respectively as negative and positive controls.
Statistical methods
Data
RESULTS
General characteristics of the study population
Prevalence of the sensitisation to mites
One hundred and forty (69.7%) patients had sensitisation to at least one of non-pollinic allergens. The prevalence of the sensitisation to the three mites tested in the current study was 67.2% (135/201), with a 95% confidence interval of 60.7-73.7%. The prevalence of the sensitisation to each of the species was 53.2% for DP, 49.8% for DF and 47.8% for BT. The distribution of the sensitisation of our participants to different species of mite is presented in Table 2 . Thirty-seven (27.4%) patients had an isolated sensitisation to one of the three species of mites and mono-sensitisation to mites (i.e. absence of sensitisation to other perennial aeroallergens) was present in 70 (51.9%) patients. Isolated sensitisation to BT was the most frequent and was found in 15 (11.1%) patients. The most common sensitisation to two species of mites was the co-sensitisation to DP and DF, which was found in 17 (12.6%) patients.
Seventy (51.9%) patients had a sensitisation to the three species of mites tested.
Determinants of the sensitisation to mites
73.9%, p=0.157) and the median age was similar between sensitised patients and non- 
DISCUSSION
This cross-sectional study conducted in a sub-Saharan African country has Shown that: 1) two out of three asthmatic patients in Yaounde have a sensitisation to mites; 2) about a third of patients have an isolated sensitisation to one of the three mites tested; 3) intermittent and Mites are minuscule cosmopolite arthropods which live and prosper in humid zones (optimal humidity of 60-80%) and at an optimal temperature of 20 to 30 o C. [5, 8] Of the hundreds of species of mites identified so far, a few are responsible for over 90% of allergenic sensitisation. [5] In most parts of the world, DP and DF account for over 70-80% of sensitisations due to mites. [7] However, during the last decade, sensitisation to BT has been increasingly reported in inter-tropical and temperate zones. [10, 19] The prevalence of the sensitisation to mites to difference species of mites among atopic patients varies substantially across regions around the world. For instance, the prevalence of sensitisation to mites in patients with asthma varies between 31% and 88% in Europe, [9] between 39% and 56% in America, [9, 10] and between 53 to 88% in Asia and Oceania. [9, 11, 12] The prevalence in our study was 67.2%, with a sensitisation to each of the three species (DP, DF and BT) found in about half of our patients. Inclusion of these three mites in the pool of allergologic test appears to be important in this setting, considering the fact that more than a third of the patients had an isolated sensitisation to one of the three mites. This could possibly reflect a cross-sensitisation due to shared allergens across species, or a true multiple sensitisation to major allergens of these mites. [7] While about half of our patients with asthma had rhinitis, the proportion was much higher among patients sensitised to mites, and regardless of the clinical form of rhinitis. This suggests that respiratory allergy to mites affects the entire respiratory tract including both the upper and the lower respiratory airways. We did not find other significant differences in the clinical characteristics between patients who were sensitised to mites and those who were not.
Alternaria and sensitisation to Blattella germanica. Indeed, a third and patients sensitised to mites were also sensitised to Blattella germanica. These associations at least in part could be explained by the cross reactivity between mites and cockroaches via tropomyosin, but could also reflect multiple sensitisation. [20] [21] [22] The association between sensitisation to mites and This study has some limitations including the reliance on skin tests alone to diagnose sensitisation and enrolment of patients from only two health facilities in the city of Yaounde.
Indeed, measurements of specific immunoglobulin E could reveal more sensitisations, in particular in patients with hyporeactivity to skin tests and may also help to differentiate between cross-sensitization and multiple sensitisations to major mite allergens. The two recruitment health facilities for this study are referral centres for chest diseases in Yaounde. It is therefore possible that patients recruited from these facilities are representative of the population of patients with asthma seen across all health facilities in the city. It remains however that recruitment from health facilities as opposed to a community-based sample could potentially bias our estimates of the prevalence of mite sensitisation. The direction of the effect of such a bias is difficult to predict, and the challenges and logistics for conducting a study of this nature in a setting with a possibly low prevalence of asthma at the population level, have to be considered.In conclusion, sensitisation to mites is frequent among patients with asthma in Yaounde, where it is frequently associated with a sensitisation to Alternaria and/or sensitisation to Blattella germanica. The presence of rhinitis in patients with asthma is suggestive of a sensitisation to mites. Systematically investigating patients with asthma for an allergy to mites as well as the determinants of such an allergy will help optimising the care of patients with asthma in this setting through a combination an aetiological treatment for the allergy with a symptomatic treatment for asthma, in order to modify the natural history of the disease. Funding: This research received no specific grant from any funding agency in the public, commercial or not-for-profit sectors.
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Diagnosis of asthma was confirmed by a specialist physician, and was based on the criteria of the Global Initiative for Asthma (GINA). [13] Demographic and clinical data were collected including: age, sex, ethnic group, known duration of asthma, family history of asthma, other existing allergic conditions (rhinitis, conjunctivitis, and atopic dermatitis) and smoking. The control of asthma was assessed with the use of the Asthma Control Questionnaire (ACQ). [16, 17] Asthma was considered to have been insufficiently controlled in the week preceding the inclusion, in the presence of an ACQ score of one or greater. [16, 17] The baseline forced expiratory volume in the first second (FEV1) was recorded for all patients in the absence of any exacerbation. Predicted FEV1 was based on the 2012 equations of the Global Lung Initiative for Blacks subjects. [18] Prick-test and standardised allergenic extracts of Stallergenes Laboratories (Anthony, France)
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DISCUSSION
This cross-sectional study conducted in a sub-Saharan African country has revealed Shown that: 1) two out of three asthmatic patients in Yaounde have a sensitisation to mites; 2) about a third of patients have an isolated sensitisation to one of the three mites tested; 3) intermittent (optimal humidity of 60-80%) and at an optimal temperature of 20 to 30 o C. [5, 8] Of the hundreds of species of mites identified so far, a few are responsible for over 90% of allergenic sensitisation. [5] In most parts of the world, DP and DF account for over 70-80% of sensitisations due to mites. [7] However, during the last decade, sensitisation to BT has been increasingly reported in inter-tropical and temperate zones. [10, 19] The prevalence of the sensitisation to mites to difference species of mites among atopic patients varies substantially across regions around the world. For instance, the prevalence of sensitisation to mites in patients with asthma varies between 31% and 88% in Europe, [9] between 39% and 56% in America, [9, 10] and between 53 to 88% in Asia and Oceania. [9, 11, 12] The prevalence in our study was 67.2%, with a sensitisation to each of the three species (DP, DF and BT) found in about half of our patients. Inclusion of these three mites in the pool of allergologic test appears to be important primordial in this setting, considering the fact that more than a third of the patients had an isolated sensitisation to one of the three mites. This could possibly reflect a cross-sensitisation due to shared allergens across species, or a true multiple sensitisation to major allergens of these mites. [7] While about half of our patients with asthma had rhinitis, the proportion was much higher among patients sensitised to mites, and regardless of the clinical form of rhinitis. This suggests that respiratory allergy to mites affects the entire respiratory tract including both the upper and the lower respiratory airways. We did not find other significant differences in the clinical characteristics between patients who were sensitised to mites and those who were not.
Indeed, measurements of specific immunoglobulin E could reveal more sensitisations, in particular in patients with hyporeactivity to skin tests and may also help to differentiate between cross-sensitization and multiple sensitisations to major mite allergens. The two recruitment health facilities for this study are referral centres for chest diseases in Yaounde. It is therefore possible that patients recruited from these facilities are representative of the population of patients with asthma seen across all health facilities in the city. It remains however that recruitment from health facilities as opposed to a community-based sample could potentially bias our estimates of the prevalence of mite sensitisation. The direction of the effect of such a bias is difficult to predict, and the challenges and logistics for conducting a study of this nature in a setting with a possibly low prevalence of asthma at the population level, have to be considered.
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